Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,236 Cr
up ₹127 Cr vs Mar 2021
- Stocks held
- 24
- unchanged
- Top 10 weight
- 61.9%
- of the portfolio in its ten largest
- Cash & debt
- 6.4%
- cash, money market and debt
- Moves this month
- 1 in · 1 out
- added to 10, trimmed 3
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In April 2021 it disclosed 24 stocks worth ₹1,236 Cr, up ₹127 Cr from Mar 2021. Its largest positions were Sun Pharmaceutical Industries Limited (8.8%), Cipla Limited (8.7%), Lupin Limited (7.2%); the ten largest together made up 61.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 63.1% of its equity. Cash and debt stood at 6.4%. Compared with Mar 2021 the fund entered 1 new stock and exited 1.
Against 229 other Sectoral / Thematic funds
Concentration
86%
Top-10 weight is higher than 86% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
81%
Holds more cash than 81% of peers
What these mean: concentration · cash
Holdings in April 2021
Download CSVEvery line the fund disclosed, with the change against Mar 2021. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 8.77% | up 1.91 pts | ₹108 Cr | up ₹32.3 Cr | Added |
| Cipla Limited | 8.69% | up 0.02 pts | ₹107 Cr | up ₹11.2 Cr | Added |
| Lupin Limited | 7.23% | down 0.46 pts | ₹89.3 Cr | up ₹4.1 Cr | Added |
| Dr. Reddy's Laboratories Limited | 6.99% | up 0.18 pts | ₹86.5 Cr | up ₹10.8 Cr | Added |
| IPCA Laboratories Limited | 6.72% | down 0.05 pts | ₹83.1 Cr | up ₹8 Cr | Added |
| Cash, TREPS & receivables | 6.43% | up 1.10 pts | ₹79.5 Cr | up ₹20.3 Cr | Added |
| Divi's Laboratories Limited | 5.52% | up 0.04 pts | ₹68.3 Cr | up ₹7.4 Cr | Added |
| Apollo Hospitals Enterprise Limited | 5.44% | down 0.06 pts | ₹67.3 Cr | up ₹6.2 Cr | Added |
| Max Healthcare Institute Limited | 4.90% | down 0.05 pts | ₹60.6 Cr | up ₹5.7 Cr | Added |
| Procter & Gamble Health Limited | 4.39% | down 0.37 pts | ₹54.3 Cr | up ₹1.5 Cr | Added |
| Intuitive Surgical Inc | 3.23% | up 0.22 pts | ₹40 Cr | up ₹6.6 Cr | Added |
| Dr. Lal Path Labs Limited | 3.06% | down 0.09 pts | ₹37.9 Cr | up ₹2.9 Cr | Added |
| Torrent Pharmaceuticals Limited | 2.88% | down 0.37 pts | ₹35.6 Cr | down ₹51 L | Trimmed |
| ICICI Lombard General Insurance Company Limited | 2.76% | down 0.36 pts | ₹34.1 Cr | down ₹46 L | Trimmed |
| Abiomed Inc | 2.59% | down 0.16 pts | ₹32 Cr | up ₹1.5 Cr | Added |
| Indoco Remedies Limited | 2.47% | up 0.06 pts | ₹30.5 Cr | up ₹3.8 Cr | Added |
| JB Chemicals & Pharmaceuticals Limited | 2.36% | down 1.21 pts | ₹29.2 Cr | down ₹10.5 Cr | Trimmed |
| Abbott Laboratories | 2.29% | down 0.22 pts | ₹28.3 Cr | up ₹49 L | Added |
| Narayana Hrudayalaya Limited | 2.17% | down 0.24 pts | ₹26.8 Cr | up ₹7 L | Held |
| Syngene International Limited | 2.08% | down 0.19 pts | ₹25.7 Cr | up ₹48 L | Added |
| Alkem Laboratories Limited | 1.94% | down 0.23 pts | ₹24 Cr | down ₹9 L | Held |
| Globus Medical Inc | 1.82% | up 1.82 pts | ₹22.5 Cr | up ₹22.5 Cr | New |
| Alembic Pharmaceuticals Limited | 1.78% | down 0.16 pts | ₹21.9 Cr | up ₹46 L | Added |
| Aarti Drugs Limited | 1.75% | down 0.16 pts | ₹21.7 Cr | up ₹48 L | Added |
| Unichem Laboratories Limited | 1.71% | down 0.12 pts | ₹21.2 Cr | up ₹80 L | Added |
What changed, Mar 2021 to Apr 2021
New New positions (1)
- Globus Medical Inc1.8% · ₹22.5 Cr
Exited Exited (1)
- Abbott India Limitedwas 0.9% · ₹9.5 Cr
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹32.3 Cr (+1.91% pts)
- Cipla Limitedup ₹11.2 Cr (+0.02% pts)
- Dr. Reddy's Laboratories Limitedup ₹10.8 Cr (+0.18% pts)
- IPCA Laboratories Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Mar 2021, the weight rose most in Healthcare Equipment & Supplies (+2.2 pts), and fell most in Pharmaceuticals & Biotechnology (−1.1 pts) and Healthcare Services (−0.6 pts).
- Healthcare Equipment & Supplies3.2% → 5.4%+2.2 pts
- Pharmaceuticals & Biotechnology64.2% → 63.1%−1.1 pts
- Healthcare Services22.2% → 21.6%−0.6 pts
- Insurance3.3% → 3.0%−0.3 pts
- Pharmaceuticals7.1% → 6.9%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Apr 2020 | Oct 2020 | Jan 2021 | Mar 2021 | Apr 2021 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.7% | 63.5% | 65.4% | 64.2% | 63.1% |
| Healthcare Services | 15.3% | 21.4% | 21.1% | 22.2% | 21.6% |
| Pharmaceuticals | 10.1% | 7.6% | 7.1% | 7.1% | 6.9% |
| Healthcare Equipment & Supplies | 1.6% | 3.8% | 3.3% | 3.2% | 5.4% |
| Insurance | 2.4% | 3.6% | 3.1% | 3.3% | 3.0% |
Allocation in Apr 2021change vs Mar 2021
- Pharmaceuticals & Biotechnology (12)63.1%▼ 1.1 pts
- Healthcare Services (6)21.6%▼ 0.6 pts
- Pharmaceuticals (3)6.9%▼ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Apr 2021
6.4%
▲ 1.1 pts vs Mar 2021
- Cash alone
- 6.5%
- cash and net receivables
- A year earlier
- 5.5%
- Apr 2020 · now ▲ 0.9 pts
- Last 12 months
- 1.8% – 8.5%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.